High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice

Biochemical and Biophysical Research Communications

Volumn 413, Issue 3, 2011, Pages 476-480

  Garg, Neha ^a   Thakur, Sachin ^a   Alex McMahan, C ^a   Adamo, Martin L ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

HFD; IGF 1; IGF 1R; Igf1r + ; SGA; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOTYPE; GLUCOSE INTOLERANCE; HETEROZYGOSITY; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; WILD TYPE;

ANIMALS; ANTIGENS, CD36; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; DIETARY FATS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HETEROZYGOTE; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, MUTANT STRAINS; RECEPTOR, IGF TYPE 1; SEX CHARACTERISTICS; SEX FACTORS;

MUS;

EID: 80053333464     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.123     Document Type: Article

References (30)

1. Wareham N.J., Franks P.W., Harding A.H. Establishing the role of gene-environment interactions in the etiology of type 2 diabetes. Endocrinology and Metabolism Clinics of North America 2002, 31:553-566.
2. van Tilburg J., van Haeften T.W., Pearson P., Wijmenga C. Defining the genetic contribution of type 2 diabetes mellitus. Journal of Medical Genetics 2001, 38:569-578.
3. Johannsen D.L., Ravussin E. Obesity in the elderly: is faulty metabolism to blame?. Aging health 2010, 6:159-167.
4. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
5. Lithell H.O., McKeigue P.M., Berglund L., Mohsen R., Lithell U.B., Leon D.A. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60years. Bmj 1996, 312:406-410.
6. Saenger P., Czernichow P., Hughes I., Reiter E.O. Small for gestational age: short stature and beyond. Endocrine Reviews 2007, 28:219-251.
7. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., Winter P.D. Fetal and infant growth and impaired glucose tolerance at age 64. Bmj 1991, 303:1019-1022.
8. Vaessen N., Janssen J.A., Heutink P., Hofman A., Lamberts S.W., Oostra B.A., Pols H.A., van Duijn C.M. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002, 359:1036-1037.
9. Klammt J., Kiess W., Pfaffle R. IGF1R mutations as cause of SGA. Best practice & research. Clinical endocrinology & metabolism 2011, 25:191-206.
10. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., Hofman A., Lamberts S.W., Oostra B.A., Pols H.A., van Duijn C.M. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001, 50:637-642.
11. Choi J.H., Kang M., Kim G.H., Hong M., Jin H.Y., Lee B.H., Park J.Y., Lee S.M., Seo E.J., Yoo H.W. Clinical and functional characteristics of a novel heterozygous mutation of the IGF1R gene and IGF1R haploinsufficiency due to terminal 15q26.2->qter deletion in patients with intrauterine growth retardation and postnatal catch-up growth failure. Journal of Clinical Endocrinology and Metabolism 2011, 96:E130-E134.
12. Raile K., Klammt J., Schneider A., Keller A., Laue S., Smith R., Pfaffle R., Kratzsch J., Keller E., Kiess W. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor 1 receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. Journal of Clinical Endocrinology and Metabolism 2006, 91:2264-2271.
13. Clemmons D.R. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Current Opinion in Pharmacology 2006, 6:620-625.
14. Moses A.C. Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1?. Endocrine development 2005, 9:121-134.
15. Fernandez A.M., Kim J.K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A.L., Filmore J., Shulman G.I., Le Roith D. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes and Development 2001, 15:1926-1934.
16. LeRoith D., Gavrilova O. Mouse models created to study the pathophysiology of Type 2 diabetes. International Journal of Biochemistry and Cell Biology 2006, 38:904-912.
17. DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture. Diabetologia 2009, 53:1270-1287.
18. Rueda-Clausen C.F., Dolinsky V.W., Morton J.S., Proctor S.D., Dyck J.R., Davidge S.T. Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes 2011, 60:507-516.
19. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
20. BJ W. Statistical Principles in Experimental Design 1971, McGraw-Hill, New York.
21. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., Turner N., Hoy A.J., Maghzal G.J., Stocker R., Van Remmen H., Kraegen E.W., Cooney G.J., Richardson A.R., James D.E. Insulin resistance is a cellular antioxidant defense mechanism. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:17787-17792.
22. Koonen D.P., Jacobs R.L., Febbraio M., Young M.E., Soltys C.L., Ong H., Vance D.E., Dyck J.R. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56:2863-2871.
23. Asghar Z., Yau D., Chan F., Leroith D., Chan C.B., Wheeler M.B. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes. Diabetologia 2006, 49:90-99.
24. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 2004, 114:147-152.
25. Shimomura I., Bashmakov Y., Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. Journal of Biological Chemistry 1999, 274:30028-30032.
26. Elam M.B., Wilcox H.G., Cagen L.M., Deng X., Raghow R., Kumar P., Heimberg M., Russell J.C. Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. Journal of Lipid Research 2001, 42:2039-2048.
27. Stahlberg N., Rico-Bautista E., Fisher R.M., Wu X., Cheung L., Flores-Morales A., Tybring G., Norstedt G., Tollet-Egnell P. Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 2004, 145:1972-1979.
28. Cheung L., Andersen M., Gustavsson C., Odeberg J., Fernandez-Perez L., Norstedt G., Tollet-Egnell P. Hormonal and nutritional regulation of alternative CD36 transcripts in rat liver - a role for growth hormone in alternative exon usage. BMC Molecular Biology 2007, 8:60.
29. Yakar S., Nunez N.P., Pennisi P., Brodt P., Sun H., Fallavollita L., Zhao H., Scavo L., Novosyadlyy R., Kurshan N., Stannard B., East-Palmer J., Smith N.C., Perkins S.N., Fuchs-Young R., Barrett J.C., Hursting S.D., LeRoith D. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 2006, 147:5826-5834.
30. Riant E., Waget A., Cogo H., Arnal J.F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009, 150:2109-2117.